Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial.

Extended safety review including patients who were lost to follow-up at 2 years revealed no evidence of an increased risk of all-cause mortality after femoropopliteal drug-coated balloon angioplasty.